Matches in Wikidata for { <http://www.wikidata.org/entity/Q105790845> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q105790845 description "clinical trial" @default.
- Q105790845 description "ensayo clínico" @default.
- Q105790845 description "ensayu clínicu" @default.
- Q105790845 description "klinisch onderzoek" @default.
- Q105790845 description "клінічне випробування" @default.
- Q105790845 description "临床试验" @default.
- Q105790845 name "A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma" @default.
- Q105790845 name "A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma" @default.
- Q105790845 type Item @default.
- Q105790845 label "A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma" @default.
- Q105790845 label "A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma" @default.
- Q105790845 prefLabel "A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma" @default.
- Q105790845 prefLabel "A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma" @default.
- Q105790845 P1050 Q105790845-DA648CA6-6729-4903-9213-6C0A64AB6403 @default.
- Q105790845 P1132 Q105790845-78D7BF38-8F4F-4868-86F9-296FF850DC22 @default.
- Q105790845 P1476 Q105790845-A5B397BB-5347-4D49-8D1A-89645621BFE5 @default.
- Q105790845 P17 Q105790845-7D32E7E8-C6B3-472D-A567-41F26B90F138 @default.
- Q105790845 P1813 Q105790845-F581D537-312D-4B4D-8784-148B86B022D8 @default.
- Q105790845 P2899 Q105790845-B65E61C6-B960-44AA-8DF5-3EC0D64612C2 @default.
- Q105790845 P3098 Q105790845-98350F69-B63B-4B1B-B365-B1A107EEB01D @default.
- Q105790845 P31 Q105790845-2FF111BB-9DEC-4472-95FE-CA9B23CF32A6 @default.
- Q105790845 P4844 Q105790845-9DEF877F-C381-4AD6-BE59-FAC798636E35 @default.
- Q105790845 P580 Q105790845-79D273EC-31E2-4FA0-80AF-A0A78665FD8A @default.
- Q105790845 P582 Q105790845-D05D750B-6364-4B5A-9923-FF49AAF2CE2D @default.
- Q105790845 P6099 Q105790845-A62F91BD-1D5D-4AFC-949E-7B4404365E49 @default.
- Q105790845 P8005 Q105790845-471D7964-6544-429A-9F78-7FC27D92C223 @default.
- Q105790845 P8363 Q105790845-9F9D6BD3-E989-48F0-B7C0-EE946E774684 @default.
- Q105790845 P1050 Q35869 @default.
- Q105790845 P1132 "+451" @default.
- Q105790845 P1476 "A Phase III, Randomized, Multicenter, Parallel-group Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma" @default.
- Q105790845 P17 Q41 @default.
- Q105790845 P1813 "ANASSA-PD" @default.
- Q105790845 P2899 "+12" @default.
- Q105790845 P3098 "NCT04665895" @default.
- Q105790845 P31 Q30612 @default.
- Q105790845 P4844 Q1002165 @default.
- Q105790845 P580 "2020-12-09T00:00:00Z" @default.
- Q105790845 P582 "2021-12-31T00:00:00Z" @default.
- Q105790845 P6099 Q42824827 @default.
- Q105790845 P8005 Q76649708 @default.
- Q105790845 P8363 Q78089383 @default.